Projects per year
Fingerprint
Dive into the research topics where Katty Zeven is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 2 Finished
-
FWOSB112: CONVICT: sentencing Cancer cells to death through ONcolytic Virotherapy and modulation of the Immune Checkpoint TIGIT
1/11/20 → 31/10/22
Project: Fundamental
-
ANI259: CONVICT: sentencing cancer cells to death through ONcolytic Virotherapy and modulation of the Immune Checkpoint TIGIT
1/11/20 → 31/10/21
Project: Fundamental
Research output
-
Emerging applications of nanobodies in cancer therapy
Awad, R. M., Meeus, F., Ceuppens, H., Ertveldt, T., Hanssens, H., Lecocq, Q., Mateusiak, L., Zeven, K., Valenta, H., De Groof, T. W. M., De Vlaeminck, Y., Krasniqi, A., De Veirman, K., Goyvaerts, C., D'Huyvetter, M., Hernot, S., Devoogdt, N. & Breckpot, K., 2022, In: International review of cell and molecular biology. 369, p. 143-199 57 p.Research output: Contribution to journal › Article › peer-review
-
Formatting and gene-based delivery of a human PD-L1 single domain antibody for immune checkpoint blockade
Awad, R. M., Lecocq, Q., Zeven, K., Ertveldt, T., De Beck, L., Ceuppens, H., Broos, K., De Vlaeminck, Y., Goyvaerts, C., Verdonck, M., Raes, G., Van Parys, A., Cauwels, A., Keyaerts, M., Devoogdt, N. & Breckpot, K., 10 Sep 2021, In: Molecular Therapy: Methods & Clinical Development. 22, 9, p. 172-182 11 p., 10.Research output: Contribution to journal › Article › peer-review
Open AccessFile5 Citations (Scopus)71 Downloads (Pure) -
Gene-based delivery of human PD-L1 single domain antibody formats for immune checkpoint blockade
Awad, R. M., Lecocq, Q., Zeven, K., Ertveldt, T., De Beck, L., Ceuppens, H., Broos, K., De Vlaeminck, Y., Goyvaerts, C., Verdonck, M., Raes, G., Van Parys, A., Cauwels, A., Keyaerts, M., Devoogdt, N. & Breckpot, K., 22 Feb 2021.Research output: Unpublished contribution to conference › Unpublished abstract
Open AccessFile31 Downloads (Pure) -
Development of LAG-3 nanobodies as potent cancer imaging tracers
Lecocq, Q., Awad, R. M., Zeven, K., De Vlaeminck, Y., De Mey, W., Debie, P., Puttemans, J., Goyvaerts, C., Raes, G., Keyaerts, M., Devoogdt, N. & Breckpot, K., 11 Dec 2019.Research output: Unpublished contribution to conference › Poster
-
Development of LAG-3 nanobodies as potent cancer imaging tracers
Lecocq, Q., Awad, R. M., Zeven, K., De Vlaeminck, Y., de Mey, W., Debie, P., Puttemans, J., Goyvaerts, C., Raes, G., Keyaerts, M., Devoogdt, N. & Breckpot, K., Dec 2019, In: Annals of Oncology. 30Research output: Contribution to journal › Meeting abstract (Journal)
-
Noninvasive imaging and inhibition of human programmed death ligand 1 (PD-L1) using nanobody K2 to improve cancer immunotherapy
Robin Maximilian Awad (Contributor), Dora Mugoli Chigoho (Contributor), Katrijn Broos (Contributor), Quentin Lecocq (Contributor), Katty Zeven (Contributor), Thomas Ertveldt (Contributor), Lien De Beck (Contributor), Hannelore Ceuppens (Contributor), Yannick De Vlaeminck (Contributor), Cleo Goyvaerts (Contributor), Steve Schoonooghe (Contributor), Vicky Caveliers (Contributor), Catarina Xavier (Contributor), Jessica Bridoux (Contributor), Geert Raes (Contributor), Marleen Keyaerts (Contributor), Nick Devoogdt (Contributor) & Karine Breckpot (Speaker)
25 Oct 2021 → 26 Oct 2021Activity: Talk or presentation › Talk or presentation at a conference
File -
-
Development of LAG-3 nanobodies as potent cancer imaging tracers
Quentin Lecocq (Speaker), Robin Maximilian Awad (Contributor), Katty Zeven (Contributor), Yannick De Vlaeminck (Contributor), Wout De Mey (Contributor), Pieterjan Debie (Contributor), Janik Puttemans (Contributor), Cleo Goyvaerts (Contributor), Geert Raes (Contributor), Marleen Keyaerts (Contributor), Nick Devoogdt (Contributor) & Karine Breckpot (Contributor)
11 Dec 2019 → 14 Dec 2019Activity: Talk or presentation › Talk or presentation at a conference
-
Single domain antibody-mediated imaging of the mouse immune checkpoint LAG-3
Quentin Lecocq (Speaker), Yannick De Vlaeminck (Contributor), Katty Zeven (Contributor), Sandrina Martens (Contributor), Geert Raes (Contributor), Nick Devoogdt (Contributor), Marleen Keyaerts (Contributor) & Karine Breckpot (Contributor)
23 Apr 2019Activity: Talk or presentation › Talk or presentation at a conference
-
Nanobody-mediated imaging of the immune checkpoint LAG-3
Quentin Lecocq (Speaker), Katty Zeven (Contributor), Yannick De Vlaeminck (Contributor), Sandrina Martens (Contributor), Sam Massa (Contributor), Cleo Goyvaerts (Contributor), Geert Raes (Contributor), Marleen Keyaerts (Contributor), Karine Breckpot (Contributor) & Nick Devoogdt (Contributor)
18 Oct 2019Activity: Talk or presentation › Talk or presentation at a conference
Thesis
-
Evaluation of single domain antibodies against the immune checkpoint LAG-3 for noninvasive nuclear imaging and therapy of cancer
Author: Devoogdt, N., Zeven, K. & Breckpot, K., 20 Jun 2019Supervisor: Lecocq, Q. (Promotor)
Student thesis: Master's Thesis
-
Targeting the novel immune checkpoint TIGIT using single domain antibodies for imaging and therapy
Author: Devoogdt, N., Breckpot, K., Keyaerts, M. & Zeven, K., 2023Student thesis: Doctoral Thesis